Abstract 4370432: Cardiovascular Event Rates by Baseline Risk and Age in a Primary Prevention Cohort from the All of Us Research Program

A Aditya Siddharth (Houston Methodist Hospital, Houston, Texas, United States) I Izza Shahid (Houston Methodist Academic Institut, Houston, Texas, United States) R Rakesh Gullapelli (Houston Methodist, HOUSTON, Texas, United States) S Sanmit Jindal (Houston Methodist, Houston, Texas, United States) Z Zulqarnain Javed (Houston Methodist, Houston, Texas, United States) M Mahmoud Al Rifai (Houston Methodist, Houston, Texas, United States) K Kershaw Patel (Houston Methodist Hospital, Houston, Texas, United States) S Sadeer Al-Kindi K Khurram Nasir

Abstract

Introduction: Among adults without established atherosclerotic cardiovascular disease (ASCVD), risk exists along a continuum, and real-world data characterizing this spectrum, particularly in untreated individuals, remain limited. In this study, we examined the incidence of major adverse cardiovascular events (MACE) in this population among untreated adults enrolled in the All of Us (AOU) Research Program. Methods: Patients with available EHR from the AOU database (Jan 1, 2000 – Oct 1, 2023) were included if they had no history of ASCVD, HF, lipid-lowering therapy, or blood pressure medications. The eligible cohort was categorized into age groups: 40–64, 45–64, 40–44, and 40–59 years. Participants were stratified into three baseline cardiovascular risk groups: high risk (low-density lipoprotein cholesterol ≥190 mg/dL, systolic blood pressure ≥160 mmHg, or DM), intermediate risk (Pooled Cohort Equation (PCE) score ≥7.5% or SBP 140–159 mmHg, no DM), and low risk (PCE <7.5%, LDL <190 mg/dL, SBP <140 mmHg, no DM). Event rates for MACE were calculated per 100 person-years (PY) across the cohort and risk groups. Results: Out of 393,596 individuals with EHR, 40,330 adults aged 40–65 met baseline criteria for primary prevention and were included in the final cohort (median follow-up: 12.4 years). Of these, 36% were high-risk, 31% intermediate-risk, and 33% low-risk. MACE rates were 2.78, 1.21, and 0.75 per 100 person-years (PY) in the high, intermediate, and low risk groups, respectively. MACE rates also increased with age: 1.11 (ages 40–45), 1.50 (40–60), and 1.72 (45–64) per 100 PY. Over a 5-year follow-up, incidence remained consistent at 2.71, 0.98, and 0.58 per 100 PY across high, intermediate, and low risk individuals. Conclusion: In this large treatment-naïve primary prevention cohort, MACE event rates varied substantially by baseline risk and age. Even “low-risk” individuals experienced non-trivial event rates, particularly with advancing age. These findings underscore the critical importance of moving beyond a one-size-fits-all approach in primary prevention.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (9)

A

Aditya Siddharth

Houston Methodist Hospital, Houston, Texas, United States

I

Izza Shahid

Houston Methodist Academic Institut, Houston, Texas, United States

R

Rakesh Gullapelli

Houston Methodist, HOUSTON, Texas, United States

S

Sanmit Jindal

Houston Methodist, Houston, Texas, United States

Z

Zulqarnain Javed

Houston Methodist, Houston, Texas, United States

M

Mahmoud Al Rifai

Houston Methodist, Houston, Texas, United States

K

Kershaw Patel

Houston Methodist Hospital, Houston, Texas, United States

S

Sadeer Al-Kindi

K

Khurram Nasir